搜尋
Translational Development Acquisition Corp
TDACU添加自選
11.310USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
234.63M總市值
--本益比TTM
關於 Translational Development Acquisition Corp 公司
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
Translational Development Acquisition Corp簡介
公司代碼TDACU
公司名稱Translational Development Acquisition Corp
上市日期Dec 23, 2024
CEOHoffman (Michael B)
員工數量- -
證券類型Unit
年結日- -
公司地址52 E 83Rd St.
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編10028
電話14132042769
網址
公司代碼TDACU
上市日期Dec 23, 2024
CEOHoffman (Michael B)
Translational Development Acquisition Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
常見問題
Translational Development Acquisition Corp的前五大股東是誰？
Translational Development Acquisition Corp的前五大股東如下：Mr. Michael B. Hoffman
有多少機構持有Translational Development Acquisition Corp(TDACU)的股份？
截至2026Q1，共有47家機構持有Translational Development Acquisition Corp的股份，合計持有的股份價值約為958.07K，占公司總股份的5.55% 。與2025Q4相比，機構持股有所增加，增幅為-14147897.00。